Post-approval studies (Phase 4)Study completedNCT02260609
What this trial is testing
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
Who this might be right for
Complex Diabetic Foot Wounds
Osiris Therapeutics 31